Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -6.72% | 174.07 | 0.0% | $1639.17m | |
| NVAX | Novavax, Inc. | -6.21% | 92.33 | 78.2% | $633.32m | |
| AMGN | Amgen, Inc. | -1.08% | 231.30 | 1.4% | $520.34m | |
| BIIB | Biogen, Inc. | -1.28% | 230.81 | 1.8% | $499.50m | |
| GILD | Gilead Sciences, Inc. | -1.93% | 69.07 | 1.0% | $465.79m | |
| BNTX | BioNTech SE | -4.47% | 161.66 | 0.0% | $438.57m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.13% | 618.11 | 2.7% | $392.67m | |
| ILMN | Illumina, Inc. | 0.32% | 384.36 | 3.3% | $386.08m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.10% | 230.84 | 1.9% | $334.35m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -4.00% | 2.88 | 0.7% | $201.32m | |
| EXAS | EXACT Sciences Corp. | -1.67% | 76.13 | 17.9% | $160.64m | |
| ARNA | Arena Pharmaceuticals, Inc. | -0.51% | 91.51 | 13.7% | $138.71m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.41% | 138.62 | 8.2% | $131.51m | |
| INCY | Incyte Corp. | -0.31% | 74.78 | 2.4% | $129.60m | |
| BBIO | BridgeBio Pharma, Inc. | -0.51% | 11.70 | 0.0% | $104.26m |
Company Profile
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.